Literature DB >> 15660503

Endothelial progenitor cells.

Aarif Y Khakoo1, Toren Finkel.   

Abstract

Endothelial progenitor cells are a circulating, bone marrow-derived cell population that appears to participate in both vasculogenesis and vascular homeostasis. Questions persist regarding their functional characteristics, as well as the precise panel of cell surface markers that uniquely define this newly described progenitor cell population. We review experimental results obtained from both animal studies and recent clinical trials that suggest this cell type may have tremendous therapeutic potential for a wide range of human diseases.

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15660503     DOI： 10.1146/annurev.med.56.090203.104149

Source DB:  PubMed          Journal:  Annu Rev Med        ISSN： 0066-4219            Impact factor:   13.739


  103 in total

1.  Inflammatory and injury signals released from the post-stenotic human kidney.

Authors:  Alfonso Eirin; Monika L Gloviczki; Hui Tang; Mario Gössl; Kyra L Jordan; John R Woollard; Amir Lerman; Joseph P Grande; Stephen C Textor; Lilach O Lerman
Journal:  Eur Heart J       Date:  2012-07-06       Impact factor: 29.983

2.  Vascular endothelial growth inhibitor (VEGI; TNFSF15) inhibits bone marrow-derived endothelial progenitor cell incorporation into Lewis lung carcinoma tumors.

Authors:  Paulina H Liang; Fang Tian; Yi Lu; Biyan Duan; Donna B Stolz; Lu-Yuan Li
Journal:  Angiogenesis       Date:  2010-12-28       Impact factor: 9.596

Review 3.  Biomaterials approach to expand and direct differentiation of stem cells.

Authors:  Chou Chai; Kam W Leong
Journal:  Mol Ther       Date:  2007-01-30       Impact factor: 11.454

4.  Humanized large-scale expanded endothelial colony-forming cells function in vitro and in vivo.

Authors:  Andreas Reinisch; Nicole A Hofmann; Anna C Obenauf; Karl Kashofer; Eva Rohde; Katharina Schallmoser; Karin Flicker; Gerhard Lanzer; Werner Linkesch; Michael R Speicher; Dirk Strunk
Journal:  Blood       Date:  2009-03-25       Impact factor: 22.113

5.  Circulating progenitor cells in chronic lung disease.

Authors:  Borna Mehrad; Michael P Keane; Brigitte N Gomperts; Robert M Strieter
Journal:  Expert Rev Respir Med       Date:  2007-08       Impact factor: 3.772

6.  Bone marrow-derived endothelial progenitor cells are a major determinant of nascent tumor neovascularization.

Authors:  Daniel J Nolan; Alessia Ciarrocchi; Albert S Mellick; Jaspreet S Jaggi; Kathryn Bambino; Sunita Gupta; Emily Heikamp; Michael R McDevitt; David A Scheinberg; Robert Benezra; Vivek Mittal
Journal:  Genes Dev       Date:  2007-06-15       Impact factor: 11.361

Review 7.  Assessing identity, phenotype, and fate of endothelial progenitor cells.

Authors:  Karen K Hirschi; David A Ingram; Mervin C Yoder
Journal:  Arterioscler Thromb Vasc Biol       Date:  2008-07-31       Impact factor: 8.311

8.  Epac-1 activator 8-O-cAMP augments renoprotective effects of syngeneic [corrected] murine EPCs in acute ischemic kidney injury.

Authors:  D Patschan; S Patschan; J T Wessels; J U Becker; S David; E Henze; M S Goligorsky; G A Müller
Journal:  Am J Physiol Renal Physiol       Date:  2009-11-11

9.  Cord blood endothelial progenitor cells as therapeutic and imaging probes.

Authors:  Branislava Janic; Ali S Arbab
Journal:  Imaging Med       Date:  2012-08-01

10.  Abnormal levels of circulating endothelial progenitor cells during exacerbations of COPD.

Authors:  Ernest Sala; Cristina Villena; Catalina Balaguer; Angel Ríos; Carlos Fernández-Palomeque; Borja G Cosío; Javier García; Aina Noguera; Alvar Agustí
Journal:  Lung       Date:  2010-01-14       Impact factor: 2.584
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.